Designed for researchers investigating mucosal repair, intestinal inflammation, and gut-immune axis modulation
GLP-1 receptor agonists, liraglutide and lixisenatide, also display neuroprotective properties in MPTP mouse models
[44] Healthcare providers should exercise extreme caution when considering melatonin therapy in patients with any degree of liver impairment and may need to consider alternative treatment approaches
Specifically, Eli Lilly sued the two telehealth companies and their affiliates for, among other things: These lawsuits are significant as they signal a more aggressive posture toward companies that fail to rigorously monitor CPOM compliance, while also intensifying scrutiny on private equity and venture capital investments in healthcare MSOs
Results: At 48 weeks, there was no difference in liver stiffness (primary endpoint) between the sema and PBO groups (MRE, estimated treatment ratio (ETR) [95%CI]: 0 .96 [0 .89-1 .03], p=0 .2798), and no difference in liver stiffness was observed at week 72
